Protalix BioTherapeutics
PLX
PLX
31 hedge funds and large institutions have $5.05M invested in Protalix BioTherapeutics in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
68% less call options, than puts
Call options by funds: $46K | Put options by funds: $142K
Holders
31
Holding in Top 10
–
Calls
$46K
Puts
$142K
Top Buyers
| 1 | +$469K | |
| 2 | +$235K | |
| 3 | +$145K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$85.4K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$40K |
Top Sellers
| 1 | -$46K | |
| 2 | -$34K | |
| 3 | -$27.1K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$8K |
| 5 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$8K |